The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Cell Sheet-Based Gene Therapy Market Between 2026 And 2030?
The cell sheet-based gene therapy market has experienced substantial expansion recently. Projections indicate its expansion from $0.68 billion in 2025 to $0.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.4%. Historically, this growth stemmed from factors such as enhanced progress in tissue engineering research, the initial integration of regenerative medicine approaches, a rise in cell-based therapeutic investigations, refinements in gene delivery methods, and a broader scope of translational research endeavors.
The cell sheet-based gene therapy market size is anticipated to undergo substantial expansion over the next few years. It is projected to reach $1.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.6%. This growth during the forecast period can be attributed to several factors, including an increasing demand for localized regenerative therapies, a rise in clinical trials for gene-modified cell therapies, the expansion of oncology and cardiology applications, growing investments in advanced tissue engineering, and an increasing focus on precision regenerative medicine. Prominent trends expected in this period encompass the expansion of multilayered and co-culture cell sheet technologies, a rising focus on localized gene expression therapies, the growing integration of regenerative medicine approaches, increased use of stem-cell derived cell sheets, and an enhanced emphasis on tissue integration and longevity.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33058&type=smp
Which Strong Drivers Are Impacting The Cell Sheet-Based Gene Therapy Market Growth?
An increasing occurrence of chronic and degenerative diseases is anticipated to fuel expansion within the cell sheet-based gene therapy market. These conditions are persistent ailments, such as cardiovascular disorders, neurodegenerative diseases, diabetes, and genetic disorders, which gradually harm tissues and organs and necessitate ongoing medical treatment. The frequency of these conditions is climbing, driven by an expanding elderly demographic and longer life expectancies in both mature and emerging economies. Cell sheet-based gene therapy aids regenerative treatment strategies for chronic and degenerative diseases by facilitating targeted tissue repair and continuous gene delivery via layered living cell constructs, thereby enhancing tissue integration and durable therapeutic results. As an illustration, the International Diabetes Federation (IDF), a non-profit organization based in Belgium, reported in April 2025 that 589 million individuals globally had diabetes in 2024, a number expected to increase to 853 million by 2050. Consequently, the growing incidence of chronic and degenerative diseases is propelling the expansion of the cell sheet-based gene therapy market.
What Are The Key Segment Divisions In The Cell Sheet-Based Gene Therapy Market Segment Structure?
The cell sheet-based gene therapy market covered in this report is segmented –
1) By Cell-Sheet Type: Monolayer Cell-Sheet Type; Co-Culture Cell-Sheet Type; Multilayered Cell-Sheet Type; Other Cell-Sheet Types
2) By Technology Type: Cell Sheet-Based Engineering Techniques; Gene Delivery Methods
3) By Source Type: Autologous; Allogenic; Stem-Cell Derived
4) By Application: Oncology; Ophthalmology; Genetic Disorders; Cardiology; Other Applications
5) By End-User: Hospitals And Clinics; Research And Academic Institutions; Biotech And Pharma Companies; Other End-Users
Subsegments:
1) By Monolayer Cell-Sheet Type: Cardiomyocyte Sheets; Epithelial Cell Sheets; Mesenchymal Stem Cell Sheets; Other Monolayer Cell Sheets
2) By Co-Culture Cell-Sheet Type: Fibroblast + Stem Cell Sheets; Endothelial + Smooth Muscle Cell Sheets; Other Co-Culture Combinations
3) By Multilayered Cell-Sheet Type: Triple-Layered Sheets; Double-Layered Sheets; Other Multilayered Configurations
4) By Other Cell-Sheet Types: Genetically Modified Cell Sheets; Hybrid Cell Sheets; Other Novel Or Experimental Sheets
Which Trends Are Contributing To Changes In The Cell Sheet-Based Gene Therapy Market?
Companies operating within the cell sheet-based gene therapy market are primarily focused on developing innovative solutions, such as autologous gene-corrected cell sheet products. These solutions aim to improve regenerative medicine outcomes, enhance treatment precision, and achieve long-term tissue repair by combining engineered cells with scaffold-free sheet constructs for targeted gene delivery and effective wound healing. Autologous gene-corrected cell sheet products are defined as therapies where a patient’s own cells are genetically modified ex vivo, then expanded into sheet constructs that maintain critical cell-to-cell interactions and extracellular matrix integrity, and subsequently applied directly to damaged tissues to promote functional integration and durable therapeutic effects. For instance, in April 2025, Abeona Therapeutics Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA), a US-based federal agency, approval for zevaskyn (prademagene zamikeracel). This product is designed to treat wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). Zevaskyn functions by delivering the active COL7A1 gene via genetically corrected cell sheets, which leads to clinically significant wound healing and pain reduction with a single application, and supports sustained type VII collagen expression at wound sites—establishing it as a breakthrough regenerative therapy and a blueprint for future innovations in cell sheet-based gene therapy.
Which Organizations Are Engaged In The Cell Sheet-Based Gene Therapy Market?
Major companies operating in the cell sheet-based gene therapy market are Hitachi Ltd., Thermo Fisher Scientific, Fujifilm Cellular Dynamics Inc. (FCDI) (FUJIFILM Holdings Corporation), Lonza Group AG, teijin regenet co. ltd., Terumo Corporation, Nikon CeLL innovation Co. Ltd., Rohto Pharmaceutical Co. Ltd., BioBridge Global, AGC Biologics, Shibuya Corporation (Shibuya Kogyo Co. Ltd.), National Resilience Inc., Takara Bio Inc., Japan Tissue Engineering Co. Ltd. (J-TEC), Medipost Co. Ltd., Cell Therapies Pty Ltd, CellSeed Inc., SCTbio, Abeona Therapeutics Inc., Foundation ENEA Tech, Cyto-Facto Inc., ENCELL Co. Ltd.
Get The Full Cell Sheet-Based Gene Therapy Market Report:
https://www.thebusinessresearchcompany.com/report/cell-sheet-based-gene-therapy-market-report
Which Region Represents The Largest Share Of The Cell Sheet-Based Gene Therapy Market?
North America was the largest region in the cell sheet based gene therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell sheet-based gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell Sheet-Based Gene Therapy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33058&type=smp
Browse Through More Reports Similar to the Global Cell Sheet-Based Gene Therapy Market 2026, By The Business Research Company
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Cell And Gene Therapy Manufacturing Services Market 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model